Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Cash & Current Investments for 7 consecutive years, with $45.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments fell 34.16% year-over-year to $45.6 million; the trailing twelve-month figure through Jun 2026 stood at $45.6 million (down 34.16% YoY), and the FY2025 full-year result was $48.4 million, down 36.09% from the prior year.
• Cash & Current Investments declined to $45.6 million in Q2 2026 per TMCI's latest filing, from $51.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $170.7 million in Q1 2023 and bottomed at $45.6 million in Q2 2026.
• Historically, Cash & Current Investments has averaged $91.0 million across 5 years, with a median of $85.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments surged 507.25% in 2022, then slumped 38.57% in 2024.
• Over 5 years, Cash & Current Investments stood at $81.3 million in 2022, then soared by 51.62% to $123.2 million in 2023, then plunged by 38.57% to $75.7 million in 2024, then tumbled by 36.09% to $48.4 million in 2025, then decreased by 5.68% to $45.6 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $45.6 million, $51.9 million, and $48.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.